ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Collins Sworn In As NIH Director

September 4, 2009

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992

NIH Funding Opportunities Listed

March 13, 2009

ONS Urges Congress To Back Anti-Tobacco Measures.

July 20, 2001